Teva Pharmaceutical Industries Limited Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (380)

Latest Posts

About This Stock More About This Stock
E Trump's Kvittle
Article By: Vivian Lewis
Tuesday, May 23, 2017 12:24 AM EDT
The President should not be blamed for all the fall in our currency, because even before he hit the scene the US$ was up way over trend, and near its 1985 peak. To revive industry, as Trump proposes, he needs a cheaper currency.
In this article: , ALV, CZZ, F, GSK, MXE, TTM, VALE, VOD, CH, ANCUF, AQUNF, BKSHF, CGRIF, CMDXF, DLKGF, NPSNY, OROCF, PPEHF, TCTZF, BLRX, SHPG, TEVA, CGEN, CUBA, INPCF, BNTC, BNTCW
Read
Teva Pharmaceuticals: How Safe Is The High Dividend Yield?
Article By: Simply Safe Dividends
Monday, May 15, 2017 5:54 PM EDT
Teva’s valuation looks cheap at first glance, but the stock’s low multiple reflects the numerous challenges facing the business.
In this article: TEVA Also: AGN
Read
Global Earnings And Company News Update
Article By: Vivian Lewis
Saturday, May 13, 2017 4:31 PM EDT
This week several international companies in different sectors reported earnings as well as market moving events are covered in this weekly report.
In this article: CPA, CZZ, AZSEY, SAXPY, TEVA, CCJ, GSK, JFC, MXE, TCTZF, FCAU, BVNRY, BNS
Read
Teva Pharmaceutical Industries Ltd. (ADR) Backs Forecast Amid Mixed Q1
Article By: Lorimer Wilson
Thursday, May 11, 2017 10:00 AM EDT
The Israeli generic pharmaceutical giant, Teva Pharmaceutical Industries Ltd (ADR) posted mixed first quarter earnings but backed its full-year outlook, as a recent acquisition began to hugely bolster its top line.
In this article: TEVA
Read
Mylan Vs. Teva: Which Is The Better Generics Stock Ahead Of Earnings?
Article By: Swarup Gupta
Wednesday, May 10, 2017 4:10 AM EDT
Coming to the two generics producers, both Mylan and Teva are undervalued relative to their broader industry. However, Teva holds the edge here with a lower EV/EBITDA value of 7.58, compared to Mylan’s value of 8.12.
In this article: MYL, TEVA
Read

PARTNER HEADLINES

Latest Tweets for $TEVA

No tweets yet!

$TEVA

Teva Surprised On The Upside Today; Reporting Q4 Sales Of $6.5 Billion
Ayelet Wolf 2/13/2017 9:33:07 PM

A nice bounce for #Teva. Happy to see such gains after the recent turmoil, $TEVA

Teva CEO Vigodman Is Out
Donald Kaplan 2/7/2017 12:05:20 AM

#Vigodman was killing #Teva. This is good news for the stock. $TEVA!

Teva CEO Vigodman Is Out
Ayelet Wolf 2/7/2017 12:02:32 AM

Someone who was born in Israel. I agree with the author that #Teva should be looking first at who can best fill the CEO role regardless of where he or she is from. $TEVA

Teva CEO Vigodman Is Out
Alexa Graham 2/7/2017 12:01:20 AM

Thanks for breaking this big news about $TEVA! But what's a sabra?

1 to 4 of 4 comments